Human CD34+ Hematopoietic Progenitors

Human CD34+ Cells from Cord Blood

Our flagship product, guaranteed over 95% pure, with a high cell viability rate. We can supply all your needs from our large stocks via our unique network of maternity partnerships.
Learn more
Tax Credit (CIR) Agreement

Abcell-bio has obtained French Research Tax Credit (CIR) agreement

Abcell-bio has obtained the CIR agreement (Crédit d’Impôt Recherche; Research Tax Credit) from the French Ministry of Education, Research and Innovation for 2023, 2024 and 2025. Thanks to this agreement, our French partners can benefit from a tax refund on contractual services used for Research and Development activities.
More
Human Stem Cells

Stem cells isolated from cord blood

Abcell-bio specializes in research and the production of stem cells isolated from cord blood. We provide a reliable source of human stem cells, ensuring continuity in your research.
Learn more
Previous slide
Next slide

Our products

Hematopoietic Cells

Abcell-Bio offers a wide variety of Hematopoietic Cells isolated from cord blood or peripheral blood: CD34+, MNC, PBMC.

View products

Human CD34+ Hematopoietic Progenitors

Abcell-Bio offers CD34+ cells isolated by immunomagnetic selection from umbilical cord blood.
View Products
Cryotube with Human Mononuclear Cells (MNC)

Human Mononuclear Cells (MNC)

Abcell-bio offers mononuclear cells (MNC) isolated from human umbilical cord blood using the Ficoll-Hypaque method.
View Products
Cryotube with Human Adult Peripheral Blood Mononuclear Cells (PBMC)

Human Adult Peripheral Blood Mononuclear Cells (PBMC)

Abcell-bio offers peripheral blood mononuclear cells (PBMC) from human adult blood isolated using the Ficoll-Hypaque method.
View Products

Maternities

We have created a partnership with maternity hospitals to collect cord blood.

Participate in research!

Become a maternity partner

“Patients feel that they are useful and participate with this cord blood donation in their child’s future medical environment.”

News

Abcell-bio Secures CIR Agreement from French Ministry: Offering Enhanced Access to Cord Blood Cells and Tax Benefits for R&D Partners

October 3, 2023

Abcell-bio arose from the will to accompany research by facilitating the access to primary resources which are difficult to get, especially cells from cord blood.

With a strong and unique network of French maternities and a robust production process, Abcell-bio also develops a Research & Development activity to face the challenges of the upcoming research.

Read More...

Did you say Red September?

September 4, 2023

Every year, we hear about Pink October and Movember, but Red September isn’t as widely recognized. This month is dedicated to raising awareness for blood cancers, which affect 45,000 individuals annually in France. ‘Live with a MPN’, a patient association, launched this initiative last year and is now rolling out its second edition.

Read More...